Affectation of the thyroid gland post SARS-CoV-2
DOI:
https://doi.org/10.56294/piii2023171Keywords:
Thyroid, Covid-19, ACE2, TMPRSS22 and Thyroiditis subacuteAbstract
Introduction: The thyroid gland is an endocrine gland located in the anterior face of the neck and is responsible for secreting the hormones T3, T4 and calcitonin. In the thyroid, a large number of receptors for angiotensin-converting enzyme 2 (ACE2) have been noted, which serves as the gateway for Covid-19, which enters that gland and can cause direct and/or indirect damage and generate various symptoms, depending on the patient, that is, whether the patient has a chronic disease or not (type 2 diabetes, hypertension) and it has been noted that when the patient has a chronic disease, the clinical picture worsens, which can generate a complication very severe: Severe Acute Respiratory Syndrome (SARS) and subacute thyroiditis.
Objectives: The objective of this systematic review is to evaluate the symptoms caused by covid-19 post infection and a possible post infection treatment.
Material and methods: This work is a systematic review whose material and methods collected will be what is available in the selected articles in the database: Pubmed and Google Scholary
References
Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. diciembre de 2021;22(4):803-15.
Darvishi M, Nazer MR, Shahali H, Nouri M. Association of thyroid dysfunction and COVID-19: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 28 de octubre de 2022;13:947594.
Trimboli P, Camponovo C, Scappaticcio L, Bellastella G, Piccardo A, Rotondi M. Thyroid sequelae of COVID-19: a systematic review of reviews. Rev Endocr Metab Disord. junio de 2021;22(2):485-91.
Giovanella L, Ruggeri RM, Ovčariček PP, Campenni A, Treglia G, Deandreis D. Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin Transl Imaging. junio de 2021;9(3):233-40.
Tian Y, Zhao J, Wang T, Wang H, Yao J, Wang S, et al. Thyroid diseases are associated with coronavirus disease 2019 infection. Front Endocrinol. 2 de septiembre de 2022;13:952049.
Senapati S, Banerjee P, Bhagavatula S, Kushwaha PP, Kumar S. Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19. J Genet. abril de 2021;100(1):12.
Pezzaioli LC, Gatta E, Bambini F, Facondo P, Gava M, Cavadini M, et al. Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature. Front Endocrinol. 10 de noviembre de 2022;13:1027047.
Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, et al. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomedicine & Pharmacotherapy. noviembre de 2020;131:110678.
Lisco G, De Tullio A, Jirillo E, Giagulli VA, De Pergola G, Guastamacchia E, et al. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J Endocrinol Invest. septiembre de 2021;44(9):1801-14.
Christensen J, O’Callaghan K, Sinclair H, Hawke K, Love A, Hajkowicz K, et al. Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID ‐19: a systematic review. Internal Medicine Journal. abril de 2022;52(4):522-9.
Tutal E, Ozaras R, Leblebicioglu H. Systematic review of COVID-19 and autoimmune thyroiditis. Travel Medicine and Infectious Disease. mayo de 2022;47:102314.
Ippolito S, Gallo D, Rossini A, Patera B, Lanzo N, Fazzino GFM, et al. SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review. J Endocrinol Invest. junio de 2022;45(6):1189-200.
Speer G, Somogyi P. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). Endocr J. 2021;68(2):129-36.
Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, et al. Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19. The Journal of Clinical Endocrinology & Metabolism. 23 de enero de 2021;106(2):e926-35.
Brancatella A, Ricci D, Cappellani D, Viola N, Sgrò D, Santini F, et al. Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series. The Journal of Clinical Endocrinology & Metabolism. 1 de octubre de 2020;105(10):e3742-6.
Wang F, Pan W, Wang H, Wang S, Pan S, Ge J. Relationship between thyroid function and ICU mortality: a prospective observation study. Crit Care. 2012;16(1):R11.
Elawady SS, Phuyal D, Shah RK, Mirza L. A Case of Subacute Thyroiditis following COVID-19 Infection. Moore WV, editor. Case Reports in Endocrinology. 31 de mayo de 2022;2022:1-3.
Gao W, Guo W, Guo Y, Shi M, Dong G, Wang G, et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. mayo de 2021;44(5):1031-40.
Dutta A, Jevalikar G, Sharma R, Farooqui KJ, Mahendru S, Dewan A, et al. Low FT3 is an independent marker of disease severity in patients hospitalized for COVID-19. Endocrine Connections. 1 de noviembre de 2021;10(11):1455-62.
Ahn J, Lee MK, Lee JH, Sohn SY. Thyroid Hormone Profile and Its Prognostic Impact on the Coronavirus Disease 2019 in Korean Patients. Endocrinol Metab. 31 de agosto de 2021;36(4):769-77.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 João Pedro Souto Silva, Erico Gerardo Laube (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
